Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Mitchell
News Release
Mitchell Automates Scan and Calibration Detection in Estimating Workflow
Enhancement comes as company’s diagnostic solutions surpass milestone
Risk & Insurance
In the News
Health Care Students Need Mental Health Resources to Face On-the-Job Pressures. Insurance Can Help
Watch Now
Virtual Event
Using Data to Influence Claim Decisions
On-Demand
Join us for a Leader-to-Leader Webinar.
Workers' Comp
Podcast
Clinical and Pharmaceutical Best Practices for PTSD
WorkCompWire
Article
Building Trust: Tips and Strategies for Improving the Injured Employee Experience
Mitchell
Article
Plugged-In: EV Collision Insights Q2 2023
Do